Evidence map›Paper›PMID 21680501›Full record

ArticleJournal of virology2011

A recombinant vesicular stomatitis virus bearing a lethal mutation in the glycoprotein gene uncovers a second site suppressor that restores fusion.

Megan L Stanifer, David K Cureton, Sean P J Whelan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. CD164 is a host factor for lymphocytic choriomeningitis virus entry.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Mechanism of membrane fusion induced by vesicular stomatitis virus G protein.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Article
  17. Article
  18. Oncolytic viruses: From bench to bedside with a focus on safety.Human vaccines & immunotherapeutics · 2015
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Megan L StaniferDepartment of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA.
David K Cureton
Sean P J Whelan
Harvard University · US

Funding

Molecular Mechanisms of Rhabdovirus EntryR01AI081842 · NIAID · HARVARD MEDICAL SCHOOL · PI WHELAN, SEAN PJ · 2010 to 2014
$2.0M
Molecular Mechanisms of Rhabdovirus EntryR56AI081842 · NIAID · HARVARD MEDICAL SCHOOL · PI WHELAN, SEAN PJ · 2009 to 2009
$167k
Mechanism of Class III viral fusion proteins.F32AI089052 · NIAID · HARVARD MEDICAL SCHOOL · PI STANIFER, MEGAN L · 2010 to 2011
$84k
NIAID NIH HHS AI081842NIAID NIH HHS F32 AI089052NIAID NIH HHS R01 AI081842NIAID NIH HHS R56 AI081842
6 · The paper itself

Abstract

Vesicular stomatitis virus (VSV), a prototype of the Rhabdoviridae family, contains a single surface glycoprotein (G) that is responsible for attachment to cells and mediates membrane fusion. Working with the Indiana serotype of VSV, we employed a reverse genetic approach to produce fully authentic recombinant viral particles bearing lethal mutations in the G gene. By altering the hydrophobicity of the two fusion loops within G, we produced a panel of mutants, W72A, Y73A, Y116A, and A117F, that were nonfusogenic. Propagation of viruses bearing those lethal mutations in G completely depended on complementation by expression of the glycoprotein from the heterologous New Jersey serotype of VSV. The nonfusogenic G proteins oligomerize and are transported normally to the cell surface but fail to mediate acid pH-triggered membrane fusion. The nonfusogenic G proteins also interfered with the ability of wild-type G to mediate fusion, either by formation of mixed trimers or by inhibition of trimer function during fusion. Passage of one recombinant virus, A117F, identified a second site suppressor of the fusion block, E76K. When analyzed in the absence of the A117F substitution, E76K rendered G more sensitive to acid pH-triggered fusion, suggesting that this compensatory mutation is destabilizing. Our work provides a set of authentic recombinant VSV particles bearing lethal mutations in G, confirms that the hydrophobic fusion loops of VSV G protein are critical for membrane fusion, and underscores the importance of the sequence elements surrounding the hydrophobic tips of the fusion loops in driving fusion. This study has implications for understanding dominant targets for inhibition of G-mediated fusion. Moreover, the recombinant viral particles generated here will likely be useful in dissecting the mechanism of G-catalyzed fusion as well as study steps of viral assembly.

Indexed as

Genes, SuppressorMembrane FusionAnimalsCell LineCell MembraneChlorocebus aethiopsCricetinaeFluorescent Antibody Technique, IndirectGenes, ViralHydrophobic and Hydrophilic InteractionsMembrane GlycoproteinsMutationProtein ConformationVero CellsVesicular stomatitis Indiana virusVesicular stomatitis New Jersey virusG protein, vesicular stomatitis virusMembrane GlycoproteinsViral Envelope ProteinsViral Fusion Proteins

Identifiers

PMID21680501
PMCPMC3147994
OpenAlexW2108410134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.